Dihexa Molecular Structure & Chemistry — Research Reference
Dihexa, an angiotensin-IV-derived peptide, possesses a distinct molecular structure and chemical profile that is foundational to its studied role in synaptogenesis research. Its specific amino acid sequence and resulting three-dimensional conformation are critical determinants of its interactions within biological systems, making it a compound of considerable interest for advanced scientific inquiry. The precise chemical architecture of Dihexa underpins its potential for specific research applications.
The intricate Dihexa molecular structure and chemistry has garnered significant attention in the scientific community, leading to numerous indexed publications on PubMed exploring its properties and research applications. Furthermore, its potential relevance in biological investigations is highlighted by several registered studies on ClinicalTrials.gov, underscoring its growing prominence as a research compound for in vitro and in vivo models.
Dihexa: An Angiotensin-IV Derived Peptide
Dihexa, a compound of significant interest in preclinical research, is formally classified as an angiotensin-derived peptide. Its structural foundation stems from angiotensin IV (AngIV), a naturally occurring peptide that emerges from the enzymatic degradation of angiotensin II and angiotensin III. This lineage positions Dihexa within a broader family of signaling molecules, yet its distinct modifications confer unique properties and research applications. The transformation from its parent AngIV involves specific structural alterations designed to enhance particular attributes, making Dihexa a focused tool for investigating specific biological pathways. Researchers exploring the vast potential of compounds like Dihexa often begin by understanding the foundational characteristics of what are research peptides, which provides a broader context for its classification and utility.
The primary mechanism under extensive investigation for Dihexa revolves around its role in synaptogenesis research. Synaptogenesis, the formation of synapses between neurons, is a fundamental process critical for learning, memory, and overall brain function. The ability of Dihexa to influence or potentially modulate this process has garnered considerable attention within neuroscience communities. Studies are continually exploring how Dihexa might interact with neural systems at a molecular level, shedding light on potential mechanisms that could contribute to synaptic plasticity and neuronal network development. These investigations predominantly utilize in vitro and in vivo animal models to meticulously map its biochemical interactions and cellular effects.
The research landscape surrounding Dihexa is robust, evidenced by its significant presence in scientific literature and clinical study registries. Numerous publications indexed in databases like PubMed document a wide array of studies exploring its synthesis, characterization, and biological activities in various research models. These publications span diverse fields, from molecular biology and neurochemistry to pharmacology and behavioral science, underscoring the multidisciplinary interest in this peptide. Furthermore, the peptide has progressed to attract attention in clinical research, with several registered studies appearing on ClinicalTrials.gov. These registrations typically pertain to early-phase investigations, primarily focusing on safety and preliminary efficacy assessments in controlled research environments, strictly adhering to regulatory guidelines for investigational compounds.
The classification of Dihexa as an angiotensin-IV derived peptide is not merely a taxonomic detail but a crucial indicator of its potential bioactivity and specificity. Angiotensin IV itself is recognized for its roles beyond cardiovascular regulation, particularly in cognitive function, where it interacts with the AT4 receptor, also known as insulin-regulated aminopeptidase (IRAP). Dihexa’s design aims to leverage or amplify certain aspects of AngIV’s biological profile, potentially by enhancing receptor affinity, stability, or pharmacokinetic properties within research settings. This targeted modification allows researchers to dissect specific aspects of AngIV pathways that are relevant to neurological function, providing a refined tool for studying complex biological phenomena with a higher degree of precision.
Primary Molecular Structure: Amino Acid Sequence and Peptide Bonds
The primary molecular structure of Dihexa is foundational to understanding its unique chemical and biological properties in research. As a hexapeptide, Dihexa consists of six amino acid residues linked together by peptide bonds, but crucially, it incorporates both standard and non-standard components, along with specific terminal modifications that differentiate it from its parent compound, Angiotensin IV. The precise sequence is N-hexanoic-Tyr-Ile-(6)Ahx-Tyr-Ile-amide. This sequence dictates its overall shape, charge distribution, and potential for interaction with biological targets. Each amino acid contributes specific side-chain characteristics—such as hydrophobicity, aromaticity, or hydrogen bonding potential—that collectively influence the peptide’s behavior in aqueous solutions and its binding capabilities.
Amino Acid Composition and Sequence
Breaking down the sequence reveals key features: the N-terminus is modified with hexanoic acid, a six-carbon fatty acid chain. This lipophilic modification can significantly impact the peptide’s solubility, membrane permeability, and stability within biological matrices during research investigations. Following this, the sequence comprises two tyrosine (Tyr) residues and two isoleucine (Ile) residues, which are standard, hydrophobic amino acids known for their bulky side chains. A critical non-standard residue, 6-aminohexanoic acid (Ahx), is positioned centrally within the peptide chain. Ahx is a synthetic amino acid analog that introduces flexibility and spacing into the peptide backbone, potentially altering its conformational landscape and accessibility to binding sites. Finally, the C-terminus is amidated, replacing the typical carboxylic acid group with an amide group (–NH2). C-terminal amidation often enhances metabolic stability by protecting against carboxypeptidase degradation and can also influence receptor affinity.
The Nature of Peptide Bonds
Central to the primary structure are the peptide bonds, which are amide linkages formed between the carboxyl group of one amino acid and the amino group of an adjacent amino acid. These bonds are planar and exhibit partial double-bond character, restricting rotation around the C-N bond and imposing conformational constraints on the peptide backbone. The atoms involved in the peptide bond (C=O and N-H) are highly polar, enabling extensive hydrogen bonding interactions both within the peptide itself and with surrounding solvent molecules or receptor sites. In Dihexa, five such peptide bonds connect the six constituent residues. The precise geometry and electronic properties of these bonds are critical for determining the peptide’s overall stability, reactivity, and its ability to adopt specific three-dimensional conformations required for biological activity in research settings.
Understanding the primary sequence of Dihexa is paramount for any research involving its use. Any deviation in this sequence, or in the specific terminal modifications, can profoundly alter its physicochemical properties and, consequently, its biological activity. Researchers rigorously confirm the exact primary structure of Dihexa preparations to ensure consistency and reproducibility in their experiments. This detailed knowledge forms the basis for investigating structure-activity relationships, designing modified analogs, and interpreting experimental outcomes related to its mechanisms of action in synaptogenesis and other neurobiological processes.
Secondary and Tertiary Structural Considerations
While hexapeptides like Dihexa are relatively small compared to proteins, their secondary and tertiary structural characteristics are profoundly important for understanding their biological activity and interactions in research contexts. These higher-order structures emerge from the intricate interplay of hydrogen bonds, hydrophobic interactions, and other non-covalent forces that dictate the peptide’s three-dimensional shape. Even subtle variations in conformation can significantly impact binding affinity, specificity, and ultimately, the observed biological effect within a research model. The inherent flexibility of short peptides, alongside specific structural elements, allows them to adopt various transient conformations, some of which may be biologically active.
Secondary Structure Elements
For a hexapeptide such as Dihexa, classical secondary structures like well-defined alpha-helices or beta-sheets are unlikely to form extensive, stable regions as they would in larger proteins. However, localized secondary structural motifs are highly probable and functionally significant. These can include various types of turns (e.g., beta-turns, gamma-turns), which reverse the direction of the polypeptide chain and are often critical for exposing specific residues for binding or interaction. The presence of the 6-aminohexanoic acid (Ahx) residue in Dihexa’s sequence is particularly noteworthy in this regard. Ahx is known to act as a ‘linker’ or ‘spacer,’ introducing increased flexibility into the peptide backbone due to its longer aliphatic chain compared to typical alpha-amino acids. This increased conformational freedom can enable the peptide to adopt diverse folded states, which might be crucial for induced fit mechanisms upon receptor binding. Hydrogen bonding between backbone amide and carbonyl groups remains a fundamental driving force for these localized structures.
Tertiary Structure and Conformational Flexibility
The tertiary structure of Dihexa, though not as complex as that of a large protein, refers to its overall three-dimensional arrangement, encompassing how all its atoms are positioned in space. For small peptides, this is often described in terms of a preferred solution conformation or a collection of rapidly interconverting conformers. The specific amino acid side chains—tyrosine (aromatic and polar), isoleucine (hydrophobic), and the hexanoic acid modification (lipophilic)—play a pivotal role in dictating these tertiary arrangements through hydrophobic packing, van der Waals interactions, and potential aromatic-aromatic interactions between the tyrosine rings. The N-terminal hexanoic acid and C-terminal amidation also influence the overall charge distribution and hydrophobicity, contributing to how the peptide folds and interacts with its environment, including membranes or aqueous solvents. This conformational flexibility is crucial in receptor-ligand interactions, where the peptide might need to adapt its shape to achieve optimal binding with its target, such as an Angiotensin IV receptor or other hypothesized binding partners in synaptogenesis research.
Factors Influencing Higher-Order Structure
Several factors in a research environment can influence the secondary and tertiary structures of Dihexa. Solvent polarity, pH, temperature, and the presence of interacting molecules (e.g., membranes, proteins, ions) can all modulate the peptide’s preferred conformation. For instance, in an aqueous environment, hydrophobic residues might tend to cluster internally to minimize solvent exposure, while in a lipidic membrane environment, these residues could be crucial for membrane association. The terminal modifications also influence charge and hydrophobicity, impacting how the peptide interacts with its surroundings. Understanding these structural dynamics is essential for designing relevant in vitro assays, predicting in vivo behavior in animal models, and interpreting biochemical data. Researchers utilize computational modeling and spectroscopic techniques, such as Circular Dichroism or NMR, to gain insights into these subtle but critical conformational preferences and dynamics, providing a comprehensive view of Dihexa’s structural attributes that contribute to its research applications.
Chemical Properties and Physicochemical Characteristics
A comprehensive understanding of Dihexa’s chemical properties and physicochemical characteristics is paramount for researchers aiming to design robust experiments, ensure compound integrity, and accurately interpret biological outcomes. These attributes directly influence the peptide’s solubility, stability, permeability, and ultimately, its bioavailability and activity within various research models. From its behavior in solution to its interaction with biological membranes, each characteristic contributes to its profile as a research-use-only compound, demanding meticulous consideration in laboratory settings.
Solubility and Hydrophobicity
The solubility of Dihexa is a critical factor for its handling and application in research. Given its N-terminal hexanoic acid modification and two isoleucine residues, Dihexa exhibits a significant degree of hydrophobicity. While peptide bonds themselves are polar, the overall balance of polar and non-polar groups determines its solubility profile. Dihexa is typically soluble in organic solvents like dimethyl sulfoxide (DMSO) and ethanol, which are often used as stock solutions in research. Its aqueous solubility can be more limited, particularly at neutral pH, though it may show increased solubility at specific pH values where ionizable groups are charged. The 6-aminohexanoic acid (Ahx) residue, with its long aliphatic chain, further contributes to the overall lipophilicity. Careful solvent selection and preparation methods, such as sonication or gentle warming, are often required to achieve homogenous solutions for in vitro and in vivo studies, ensuring consistent dosing and reproducible experimental results.
pH Stability and Ionization State
The stability of Dihexa across a range of pH values is a crucial physicochemical characteristic. Peptide bonds can undergo hydrolysis, particularly under extreme acidic or basic conditions, leading to degradation and loss of activity. The terminal modifications—N-hexanoic acid (non-ionizable as an amide) and C-terminal amide (non-ionizable)—along with the ionizable groups of the tyrosine residues (phenolic hydroxyl, pKa ~10.1) and the N-terminal amine of the first amino acid (though blocked by hexanoic acid) and the C-terminal carboxylic acid (amidated) will define its overall charge state. At physiological pH (around 7.4), Dihexa is expected to have a relatively neutral charge profile, which can contribute to its ability to traverse biological membranes. Understanding the pKa values of any remaining ionizable groups (e.g., the phenolic hydroxyls of Tyr) is essential for predicting its charge and conformation at different pH values, influencing its interaction with charged biomolecules and its stability during storage and experimental use.
Molecular Weight and Purity Considerations
Dihexa has a precise molecular weight, which is a direct sum of its constituent amino acids and modifications. This specific mass is a key identifier used in analytical characterization (e.g., mass spectrometry). Beyond its exact mass, the purity of Dihexa is perhaps the most critical physicochemical characteristic for reliable research. Impurities, such as truncated sequences, oxidized forms, or side products from synthesis, can confound experimental results, leading to misinterpretations of activity or toxicity. High-performance liquid chromatography (HPLC) purity, typically expressed as a percentage, is a standard measure of quality. Researchers demand high-purity Dihexa, usually >98%, to ensure that observed effects are attributable solely to the intended compound. Regular assessment of purity, often through a Certificate of Analysis (CoA), is therefore indispensable for maintaining the integrity and reproducibility of research studies.
Furthermore, other physicochemical characteristics such as hygroscopicity (tendency to absorb moisture), optical rotation, and melting point contribute to its complete profile. Peptides are often hygroscopic, necessitating careful storage in desiccated environments to prevent degradation and maintain stability. The optical rotation, while less commonly used for routine characterization of synthetic peptides, confirms the chirality of the constituent amino acids. All these properties collectively inform the proper handling, storage, and experimental application of Dihexa, ensuring that researchers can confidently explore its complex biological roles in synaptogenesis research and beyond.
Dihexa Synthesis Pathways and Purity Assessment
The synthesis of research-grade Dihexa is a critical process that directly impacts its utility and reliability in scientific investigations. Given its hexapeptide nature with specific terminal modifications and a non-standard amino acid, careful selection and execution of synthesis methodologies are essential to yield a product of high purity and structural integrity. The subsequent rigorous purity assessment is equally vital to ensure that the material used in research studies is consistently well-defined and free from significant contaminants, which could otherwise confound experimental results.
Solid-Phase Peptide Synthesis (SPPS)
The predominant method for synthesizing Dihexa, like many research peptides, is Solid-Phase Peptide Synthesis (SPPS). This technique, pioneered by R.B. Merrifield, offers significant advantages for sequential peptide chain elongation. In SPPS, the C-terminal amino acid is first anchored to an insoluble polymer resin. Subsequent amino acids are then added one by one in a stepwise manner, reacting their activated carboxyl group with the free amine of the resin-bound peptide. Each coupling step is followed by a deprotection step to free the amine for the next addition. For Dihexa, the synthesis begins by attaching the C-terminal isoleucine (amidated as NH2) to a suitable resin, such as Rink amide resin, to ensure the desired C-terminal amidation. The hexanoic acid modification is typically introduced at the final N-terminal coupling step, and the 6-aminohexanoic acid (Ahx) is incorporated as a standard building block during its turn in the sequence. SPPS is favored for its ease of automation, efficient purification of intermediates (by simple washing), and ability to synthesize complex sequences, but requires meticulous control over reaction conditions to minimize side reactions and maximize coupling efficiency.
Challenges in Dihexa Synthesis
Synthesizing Dihexa presents several specific challenges that require careful optimization. The incorporation of non-standard amino acids like 6-aminohexanoic acid necessitates the use of appropriately protected derivatives during SPPS. The N-terminal hexanoic acid modification requires a specific acylation step at the end of the chain elongation, ensuring complete reaction without introducing unwanted byproducts. Furthermore, the hydrophobic nature of some residues (e.g., isoleucine, the hexanoic acid chain) can sometimes lead to aggregation issues on the resin, hindering coupling efficiency and increasing the risk of deletion sequences. Protecting group strategies for amino acid side chains (e.g., tyrosine’s phenolic hydroxyl) must be chosen carefully to remain stable throughout the synthesis steps but be readily removable during the final cleavage from the resin and deprotection process, typically employing strong acids like trifluoroacetic acid (TFA). Incomplete coupling or side reactions can lead to a mixture of desired product and various impurities, underscoring the necessity for robust purification.
Purity Assessment and Quality Control
Post-synthesis, crude Dihexa requires extensive purification and rigorous quality assessment to meet research-grade standards. Reverse-phase High-Performance Liquid Chromatography (RP-HPLC) is the primary technique for purification, separating the desired peptide from truncated sequences, deleted peptides, and other byproducts based on differences in hydrophobicity. After purification, the purity of Dihexa is routinely confirmed by analytical RP-HPLC, with a typical requirement of >98% purity for research applications. Mass Spectrometry (MS), particularly Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF), is indispensable for verifying the exact molecular weight and confirming the correct sequence, detecting any unexpected modifications or deletions. Amino acid analysis (AAA) can further confirm the correct ratio of constituent amino acids. Nuclear Magnetic Resonance (NMR) spectroscopy can be employed for detailed structural elucidation, though it is less common for routine batch release. Adherence to these strict quality control measures, often documented in a Certificate of Analysis (CoA), ensures the provision of reliable and consistent Dihexa for all research purposes.
The commitment to high standards in both synthesis and purity assessment is paramount for suppliers of research-use-only peptides. Researchers rely on these stringent measures to ensure that their experimental results are valid and reproducible, eliminating compound quality as a variable. This thorough approach provides confidence in exploring Dihexa’s complex roles in synaptogenesis research and other neurobiological investigations.
Structural Activity Relationships (SAR) in Research Contexts
Structural Activity Relationships (SAR) studies are fundamental in peptide research, offering profound insights into how specific molecular features of a compound like Dihexa correlate with its observed biological activities. By systematically modifying parts of the Dihexa molecule and observing changes in its effects within research models, scientists can pinpoint critical structural determinants for its activity in synaptogenesis. This iterative process of synthesis and biological evaluation is crucial for elucidating the precise mechanism by which Dihexa interacts with its biological targets and for guiding the development of related compounds for specific research applications.
Impact of N-Terminal Hexanoic Acid Modification
One of the most distinguishing features of Dihexa is its N-terminal hexanoic acid modification. SAR studies typically investigate the role of such modifications by either removing them or replacing them with different chain lengths or chemical functionalities. It is hypothesized that the hexanoic acid group significantly enhances Dihexa’s lipophilicity, which could contribute to improved membrane permeability, potentially facilitating its entry into cells or passage across biological barriers in animal models. This increased lipophilicity might also influence its binding affinity by promoting hydrophobic interactions with receptor binding pockets. Conversely, variations in the alkyl chain length could alter this balance, affecting both pharmacokinetic properties (e.g., stability, distribution) and pharmacodynamic properties (e.g., receptor binding, signal transduction). Research aims to determine if this modification primarily aids in delivery or directly contributes to receptor interaction specificity, particularly within the complex environment of neuronal membranes.
Role of Specific Amino Acid Residues
Each amino acid in the N-hexanoic-Tyr-Ile-(6)Ahx-Tyr-Ile-amide sequence contributes to the overall activity, and SAR studies systematically probe their individual importance. The two tyrosine (Tyr) residues, with their aromatic rings and phenolic hydroxyl groups, are often critical for receptor recognition and hydrogen bonding. Substituting Tyr with other aromatic or non-aromatic amino acids can reveal if the aromaticity, the hydroxyl group, or both are essential. Similarly, the isoleucine (Ile) residues, being hydrophobic and branched, likely contribute to hydrophobic interactions within a binding site. Replacing Ile with other hydrophobic residues (e.g., Val, Leu) or even hydrophilic ones can indicate the exact spatial requirements for hydrophobic pockets. The unique 6-aminohexanoic acid (Ahx) residue
Frequently Asked Questions
What is the primary molecular class of Dihexa?
Dihexa is classified as an angiotensin-derived peptide, specifically an analog or mimetic of angiotensin IV, studied for its distinct properties in research models.
How is Dihexa structurally related to Angiotensin IV?
Dihexa is designed as a small peptide structurally related to angiotensin IV (Ang IV), often referred to as an Ang IV derivative or mimetic, with structural modifications intended to potentially enhance or modulate specific biological activities compared to the parent peptide for research purposes.
What are the key chemical bonds present in the Dihexa molecular structure?
As a peptide, Dihexa primarily features amide bonds (also known as peptide bonds) that link its constituent amino acid residues together. Additionally, it contains standard covalent bonds (e.g., carbon-carbon, carbon-hydrogen, carbon-oxygen, carbon-nitrogen) within the amino acid side chains and backbone.
What is the typical approach to synthesizing Dihexa for research purposes?
Dihexa is typically synthesized using established methods for peptide synthesis, primarily solid-phase peptide synthesis (SPPS) or, less commonly, liquid-phase peptide synthesis (LPPS). These methods involve the sequential addition of protected amino acids, followed by cleavage, purification, and detailed characterization to ensure research-grade purity.
What physicochemical properties are important for Dihexa in research?
Key physicochemical properties critical for Dihexa research include its precise molecular weight, specific solubility profile (e.g., in aqueous solutions, organic solvents, or mixed systems), stability under various conditions (such as pH, temperature, and exposure to light or oxygen), and its overall purity. These characteristics are fundamental for accurate experimental design and reproducible research outcomes.
How is the purity of Dihexa typically assessed in a research setting?
The purity and identity of Dihexa in a research setting are rigorously assessed using a combination of advanced analytical techniques. These commonly include High-Performance Liquid Chromatography (HPLC) for quantitative purity and retention time comparison, Mass Spectrometry (MS) for molecular weight verification and fragmentation analysis, and Nuclear Magnetic Resonance (NMR) spectroscopy for detailed structural elucidation and confirmation of identity.
Why is understanding Dihexa’s molecular structure critical for research?
A comprehensive understanding of Dihexa’s molecular structure is paramount for various research endeavors. It enables scientists to hypothesize and investigate its precise mechanism of action, predict its potential interactions with specific biological targets (e.g., receptors, enzymes), and rationally guide the design of structural modifications for advanced structure-activity relationship (SAR) studies.
Does Dihexa exhibit stereoisomers, and if so, what are their implications for research?
Peptides like Dihexa are composed of amino acids, which typically possess chiral centers (except glycine). Therefore, Dihexa can exhibit stereoisomerism. Maintaining the specific stereochemistry (predominantly L-amino acids in naturally derived peptides) is crucial in research, as the precise three-dimensional arrangement of atoms significantly influences the peptide’s biological activity, target recognition, and overall efficacy in experimental models.
Scientific References
All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.